NCT04525937

Brief Summary

Common barriers to receiving appropriate guideline-driven care for patients with severe aortic stenosis include referral biases by primary care providers (lack of provider education), patient comorbidities (degree of fragility), as well as psychosocial issues and cultural barriers. Additionally, race, ethnicity, socioeconomic status (SES) and education level are shown to be persistent barriers to accessing healthcare services and healthcare systems, creating a significant practice gap between various patient populations. The most recent transcatheter valve therapies (TVT) registry data show that \>94% of TAVR recipients are Caucasian, followed by less than 4% of African-Americans and Hispanics, respectively. There is a critical need to understand the barriers to treatment and care among severe aortic valve disease patients of disparate groups. This study is a multi-center, retrospective and prospective cohort study of patients diagnosed with severe aortic stenosis. Additionally, we will be surveying referring primary care providers, cardiologists and cardiovascular surgeons to assess their current referral practices for patients with severe aortic stenosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 4, 2018

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 25, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2022

Completed
Last Updated

April 8, 2022

Status Verified

April 1, 2022

Enrollment Period

4.2 years

First QC Date

August 20, 2020

Last Update Submit

April 7, 2022

Conditions

Keywords

Aortic Valve StenosisDisparities

Outcome Measures

Primary Outcomes (2)

  • Patient Mortality

    30 days and 1 year

  • MACE (Major Adverse Cardiac Event)

    30 days and 1 year

Secondary Outcomes (1)

  • Referring physician- related barriers/biases.

    through study completion, an average of 1 year

Study Arms (2)

Patients with Severe Aortic Stenosis with Disparities

Patients will complete a survey and their aortic stenosis will be clinically followed at 30 days and one year

Other: Patient Questionnaire

Medical Providers with Disparities

Referring primary care providers complete a questionnaire on their referral practices for patients with severe aortic stenosis

Other: Provider Questionnaire

Interventions

Patient Questionnaire

Patients with Severe Aortic Stenosis with Disparities

Provider Questionnaire

Medical Providers with Disparities

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients: \- Over 18 years of age with echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score who have a disparate condition Providers: \- Referring primary care providers, cardiologists and cardiovascular surgeons at the study sites.

You may qualify if:

  • Disparity/Diversity background (either race/ethnicity, low SES (adults with incomes at or below the federal poverty level (family income to poverty ratio, ≤1), language (non-English speaker) or education (≤9 years of education))
  • Patient scheduled for transcatheter aortic valve replacement using the Edwards Sapien valve, OR recently implanted with Edwards Sapien valve (up to 1 year post-TAVR)
  • Echocardiographic diagnosis of severe, symptomatic AS and intermediate to high surgical risk per Society of Thoracic Surgeons (STS) mortality risk-score

You may not qualify if:

  • Age \< 18
  • Patients who do not allow their records to be used for research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, 55407, United States

RECRUITING

MeSH Terms

Conditions

Aortic Valve Stenosis

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Mario Goessl, MD, PhD

    Minneapolis Heart Institute Foundation

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Schwager, RN, BSN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2020

First Posted

August 25, 2020

Study Start

June 4, 2018

Primary Completion

August 1, 2022

Study Completion

August 1, 2022

Last Updated

April 8, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations